C3 Matched Antibody Pair (157) (APMAB-157LY)

Yuan, K., Ye, J., Liu, Z., Ren, Y., He, W., Xu, J., ... & Yuan, Y. (2020). Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression. Journal of Experimental & Clinical Cancer Research, 39(1), 1-15.

Mastaglio, S., Ruggeri, A., Risitano, A. M., Angelillo, P., Yancopoulou, D., Mastellos, D. C., ... & Ciceri, F. (2020). The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clinical Immunology, 215, 108450.

Mastellos, D. C., da Silva, B. G. P., Fonseca, B. A., Fonseca, N. P., Auxiliadora-Martins, M., Mastaglio, S., ... & Lambris, J. D. (2020). Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clinical Immunology, 220, 108598.

Liao, D. S., Grossi, F. V., El Mehdi, D., Gerber, M. R., Brown, D. M., Heier, J. S., ... & Francois, C. G. (2020). Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial. Ophthalmology, 127(2), 186-195.

Zhang, L. Y., Pan, J., Mamtilahun, M., Zhu, Y., Wang, L., Venkatesh, A., ... & Yang, G. Y. (2020). Microglia exacerbate white matter injury via complement C3/C3aR pathway after hypoperfusion. Theranostics, 10(1), 74.

Wu, T., Dejanovic, B., Gandham, V. D., Gogineni, A., Edmonds, R., Schauer, S., ... & Hanson, J. E. (2019). Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell reports, 28(8), 2111-2123.

Bosco, A., Anderson, S. R., Breen, K. T., Romero, C. O., Steele, M. R., Chiodo, V. A., ... & Vetter, M. L. (2018). Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma. Molecular Therapy, 26(10), 2379-2396.

Sorbara, M. T., Foerster, E. G., Tsalikis, J., Abdel-Nour, M., Mangiapane, J., Sirluck-Schroeder, I., ... & Philpott, D. J. (2018). Complement C3 drives autophagy-dependent restriction of cyto-invasive bacteria. Cell host & microbe, 23(5), 644-652.

Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., ... & Lemere, C. A. (2017). Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice. Science translational medicine, 9(392).

Mastellos, D. C., Reis, E. S., Ricklin, D., Smith, R. J., & Lambris, J. D. (2017). Complement C3-targeted therapy: replacing long-held assertions with evidence-based discovery. Trends in immunology, 38(6), 383-394.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-C3 Recombinant Antibody (10K164)

Mouse Anti-C3 Recombinant Antibody (053A-1149.3.1.4)

Rat Anti-C3 Recombinant Antibody (RMC11H9)

Mouse Anti-C3 Recombinant Antibody (CBXC-0011)

Mouse Anti-C3 Recombinant Antibody (6A529)

Rat Anti-C3 Recombinant Antibody (CBFYC-0629)

Mouse Anti-C3 Recombinant Antibody (CBFYC-0624)

Mouse Anti-C3 Recombinant Antibody (2A6B3)

Mouse Anti-C3 Recombinant Antibody (CBXC-0013)

Mouse Anti-C3 Recombinant Antibody (10D230)

Isotype control